MedTrace Logo

Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis

NCT00315471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2022-07-12

No results posted yet for this study

Summary

Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu's arteritis.

Conditions

  • Takayasu's Arteritis

Sponsors & Collaborators

  • Office of Rare Diseases (ORD)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Rare Diseases Clinical Research Network

    collaborator NETWORK

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Peter A. Merkel, MD, MPH · Vasculitis Clinical Research Consortium (VCRC)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315471 on ClinicalTrials.gov